{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:39:41Z","timestamp":1792615181930,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier","isbn-type":[{"value":"9780443293405","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.pmbts.2024.03.016","type":"book-chapter","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T16:11:04Z","timestamp":1711815064000},"page":"265-290","source":"Crossref","is-referenced-by-count":2,"title":["Amyloid fibril cytotoxicity and associated disorders"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2024.03.016_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pbiomolbio.2022.08.007","article-title":"Advances in the understanding of protein misfolding and aggregation through molecular dynamics simulation","volume":"175","author":"Rahman","year":"2022","journal-title":"Prog Biophys Mol Biol"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.016_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/biology10050394","article-title":"Amyloids: the history of toxicity and functionality","volume":"10","author":"Yakupova","year":"2021","journal-title":"Biology"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/joim.12506","article-title":"Current and future treatment of amyloid diseases","volume":"280","author":"Ankarcrona","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib4","article-title":"Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis","volume":"280","author":"Lewkowicz","year":"2022","journal-title":"Biophys\u00a0Chem"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.016_bib5","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/ijms19092677","article-title":"Targeting amyloid aggregation: an overview of strategies and mechanisms","volume":"19","author":"Giorgetti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib6","doi-asserted-by":"crossref","first-page":"a033878","DOI":"10.1101\/cshperspect.a033878","article-title":"The amyloid phenomenon and its significance in biology and medicine","volume":"12","author":"Dobson","year":"2020","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"22","key":"10.1016\/bs.pmbts.2024.03.016_bib7","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.3390\/ijms21228651","article-title":"Therapeutic strategies to reduce the toxicity of misfolded protein oligomers","volume":"21","author":"Kreiser","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0972-2327.144284","article-title":"Toxic species in amyloid disorders: oligomers or mature fibrils","volume":"18","author":"Verma","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.016_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0030173","article-title":"Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils,\u201d","volume":"3","author":"Cheon","year":"2007","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00465-0","article-title":"Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology","volume":"16","author":"Rahman","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.016_bib11","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.bbamem.2018.02.022","article-title":"Amyloid growth and membrane damage: current themes and emerging perspectives from theory and experiments on A\u03b2 and hIAPP","volume":"1860","author":"Sciacca","year":"2018","journal-title":"Biochim\u00a0Biophys\u00a0Acta (BBA)\u2014Biomembr"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.016_bib12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.bbamem.2018.03.014","article-title":"Molecular mechanisms of membrane-associated amyloid aggregation: computational perspective and challenges","volume":"1860","author":"Press-Sandler","year":"2018","journal-title":"Biochim\u00a0Biophys\u00a0Acta (BBA)\u2014Biomembr"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/biophysica1020011","article-title":"Amyloid-mediated mechanisms of membrane disruption","volume":"1","author":"Sciacca","year":"2021","journal-title":"Biophysica"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.016_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00018-022-04166-9","article-title":"Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies","volume":"79","author":"Cascella","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol"},{"issue":"17","key":"10.1016\/bs.pmbts.2024.03.016_bib16","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","article-title":"Oxidative stress occurs prior to amyloid A\u03b2 plaque formation and tau phosphorylation in Alzheimer\u2019s disease: role of glutathione and metal ions","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"17","key":"10.1016\/bs.pmbts.2024.03.016_bib17","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers","volume":"280","author":"Demuro","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib18","first-page":"137","article-title":"Calcium channel blockers and Alzheimer's disease","volume":"7","author":"Tan","year":"2012","journal-title":"Neural Regen Res"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.642623","article-title":"\u201cMembrane interactions and toxicity by misfolded protein oligomers","volume":"9","author":"Gonzalez-Garcia","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/bs.apcsb.2019.06.001","article-title":"Cytotoxic species in amyloid-associated diseases: oligomers or mature fibrils","volume":"118","author":"Siddiqi","year":"2019","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev-biochem-072611-130030","article-title":"Systemic amyloidoses","volume":"82","author":"Blancas-Mej\u00eda","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib23","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjcard.2022.10.057","article-title":"Current understanding of systemic amyloidosis and underlying disease mechanisms","volume":"185","author":"Picken","year":"2022","journal-title":"Am J Cardiology"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib24","first-page":"59","article-title":"Amyloidosis of the urogenital system","volume":"8","author":"Park","year":"2010","journal-title":"Korean J Urol\u00a0Oncol"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.03.016_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib26","article-title":"Light chain amyloidosis","volume":"10","author":"Milani","year":"2018","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.016_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443200","article-title":"Immunoglobulin light-chain amyloidosis: from basics to new developments in diagnosis, prognosis and therapy","volume":"135","author":"Muchtar","year":"2016","journal-title":"Acta Haematol"},{"issue":"15","key":"10.1016\/bs.pmbts.2024.03.016_bib28","first-page":"2304","article-title":"Transthyretin deposition in familial amyloidotic polyneuropathy","volume":"19","author":"Saraiva","year":"2012","journal-title":"Curr Med\u00a0Chem"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.03.016_bib29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/clc.23434","article-title":"Diagnosis and treatment of transthyretin\u2010related amyloidosis cardiomyopathy","volume":"43","author":"Teng","year":"2020","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib30","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1038\/s41467-022-34636-4","article-title":"Amyloid fibril structure from the vascular variant of systemic AA amyloidosis","volume":"13","author":"Banerjee","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","author":"Real De As\u00faa","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"29","key":"10.1016\/bs.pmbts.2024.03.016_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029638","article-title":"Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: a case report","volume":"101","author":"Xu","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib33","doi-asserted-by":"crossref","first-page":"1158083","DOI":"10.3389\/fimmu.2023.1158083","article-title":"The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13023-020-1300-5","article-title":"Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study","volume":"15","author":"Schmidt","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12881-019-0755-5","article-title":"A new genetic variant of hereditary apolipoprotein AI amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options","volume":"20","author":"Moutafi","year":"2019","journal-title":"BMC Med Genet"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.03.016_bib36","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/biomedicines10071578","article-title":"Apolipoprotein A-II, a player in multiple processes and diseases","volume":"10","author":"Florea","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.016_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.5770","article-title":"Clinical ApoA\u2010IV amyloid is associated with fibrillogenic signal sequence","volume":"255","author":"Canetti","year":"2021","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib38","doi-asserted-by":"crossref","first-page":"10353","DOI":"10.1038\/ncomms10353","article-title":"D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile","volume":"7","author":"Valleix","year":"2016","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.016_bib39","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/14789450.2019.1659137","article-title":"Fibrinogen alpha amyloidosis: insights from proteomics","volume":"16","author":"Chapman","year":"2019","journal-title":"Expert Rev Proteom"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib40","first-page":"1447","article-title":"Beta-2 microglobulin amyloidosis: past, present, and future","volume":"12","author":"Portales","year":"2020","journal-title":"Am Soc Nephrol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1827.2001.01156.x","article-title":"Pathogenesis of \u03b22\u2010microglobulin amyloidosis","volume":"51","author":"Ohashi","year":"2001","journal-title":"Pathol Int"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.carpath.2019.05.002","article-title":"The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosis","volume":"42","author":"Morris","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.812096","article-title":"Molecular dynamics of lysozyme amyloid polymorphs studied by incoherent neutron scattering","volume":"8","author":"Matsuo","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.016_bib44","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbamem.2018.02.020","article-title":"IAPP in type II diabetes: basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies","volume":"1860","author":"Asthana","year":"2018","journal-title":"Biochim\u00a0Biophys\u00a0Acta (BBA)-Biomembr"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnmol.2020.00035","article-title":"Islet amyloid polypeptide: a partner in crime with A\u03b2 in the pathology of alzheimer's disease","volume":"13","author":"Raimundo","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.842582","article-title":"Linking Alzheimer\u2019s disease and type 2 diabetes: characterization and inhibition of cytotoxic A\u03b2 and IAPP hetero-aggregates","volume":"9","author":"Al Adem","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","article-title":"New approaches for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Fish","year":"2019","journal-title":"Bioorg\u00a0Med Chem Lett"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.609073","article-title":"Modulation of \u03b2-amyloid fibril formation in Alzheimer\u2019s disease by microglia and infection","volume":"13","author":"Brown","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J Cent Nerv Syst Dis"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.03.016_bib51","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4103\/1673-5374.235013","article-title":"Subcellular localization of alpha-synuclein aggregates and their interaction with membranes","volume":"13","author":"Miraglia","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson\u2019s disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front Pharmacol"},{"issue":"6923","key":"10.1016\/bs.pmbts.2024.03.016_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.308.6923.281","article-title":"Parkinson's disease and its management","volume":"308","author":"Hughes","year":"1994","journal-title":"BMJ: Br Med J"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.016_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","article-title":"Treatment of Huntington\u2019s disease","volume":"11","author":"Frank","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.682172","article-title":"Small, seeding-competent huntingtin fibrils are prominent aggregate species in brains of zQ175 Huntington\u2019s disease knock-in mice","volume":"15","author":"Schindler","year":"2021","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.016_bib57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.581907","article-title":"Amyotrophic lateral sclerosis: proteins, proteostasis, prions, and promises","volume":"14","author":"McAlary","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.03.016_bib59","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.freeradbiomed.2019.12.017","article-title":"Oxidative misfolding of Cu\/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation","volume":"147","author":"Anzai","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.016_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2013.03.077","article-title":"Disorders of protein misfolding: alpha-1-antitrypsin deficiency as prototype","volume":"163","author":"Silverman","year":"2013","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.03.016_bib62","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.0802864","article-title":"Evidence for unfolded protein response activation in monocytes from individuals with \u03b1-1 antitrypsin deficiency","volume":"184","author":"Carroll","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmedc.2011.04.001","article-title":"Alpha-1 antitrypsin deficiency","volume":"4","author":"Kelly","year":"2011","journal-title":"Resp Med CME"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101391","article-title":"Living with the enemy: from protein-misfolding pathologies we know, to those we want to know","volume":"70","author":"Emwas","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2024.03.016_bib65","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl Sci Rare Dis"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/1678-4685-gmb-2018-0159","article-title":"Lysosomal diseases: overview on current diagnosis and treatment","volume":"42","author":"Poswar","year":"2019","journal-title":"Genet Mol Biol"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib67","series-title":"Viral Infections of Humans: Epidemiology and Control","first-page":"1","article-title":"Prion diseases,","author":"Belay","year":"2023"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.016_bib68","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/ijms23031232","article-title":"Prion protein: the molecule of many forms and faces","volume":"23","author":"Kova\u010d","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570045","article-title":"Tau protein and its role in blood\u2013brain barrier dysfunction","volume":"13","author":"Michalicova","year":"2020","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-022-00293-2","article-title":"Propagation of tau and \u03b1-synuclein in the brain: therapeutic potential of the glymphatic system","volume":"11","author":"Lopes","year":"2022","journal-title":"Transl Neurodegener"},{"key":"10.1016\/bs.pmbts.2024.03.016_bib71","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"2-3","key":"10.1016\/bs.pmbts.2024.03.016_bib72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"History of the amyloid fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"J Struct Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.016_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.131","article-title":"Amyloid formation by globular proteins under native conditions","volume":"5","author":"Chiti","year":"2009","journal-title":"Nat Chem Biol"}],"container-title":["Progress in Molecular Biology and Translational Science","The Hidden World of Protein Aggregation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T07:23:26Z","timestamp":1753341806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117324000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443293405"],"references-count":73,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2024.03.016","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}